Evidence map›Paper›PMID 35268357›Full record

ArticleJournal of clinical medicine2022

Detection of

Jessica Petiti, Federico Itri, Elisabetta Signorino, Antonio Frolli, Carmen Fava, Marco Armenio, Silvia Marini, Emilia Giugliano, Marco Lo Iacono, Giuseppe Saglio and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. The molecular management of classic myeloproliferative neoplasm.Journal of the Egyptian National Cancer Institute · 2025
    Review
  3. Cancers · 2022
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jessica PetitiDepartment of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.ORCID 0000-0001-8640-2462
Federico ItriDepartment of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.ORCID 0000-0002-3532-5281
Elisabetta SignorinoDepartment of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
Antonio FrolliDepartment of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
Carmen FavaDepartment of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
Marco ArmenioDepartment of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy.
Silvia MariniDivision of Internal Medicine and Hematology, San Luigi Gonzaga Hospital, 10043 Orbassano, Italy.
Emilia GiuglianoDivision of Internal Medicine and Hematology, San Luigi Gonzaga Hospital, 10043 Orbassano, Italy.
Marco Lo IaconoDepartment of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.ORCID 0000-0002-3936-4472
Giuseppe SaglioDepartment of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
Daniela CilloniDepartment of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.ORCID 0000-0001-6346-4791
University of Turin · ITOspedale San Luigi Gonzaga · IT

Funding

Italian Association for Cancer Research 23344
6 · The paper itself

Abstract

Mutations in

Indexed as

MDSMPNPNA-PCR clampingSF3B1 p.Lys700Glu

Identifiers

PMID35268357
PMCPMC8911290
OpenAlexW4214574740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.